Neurocrine (0K6R) Ratios
Neurocrine Ratios
GB:0K6R's free cash flow for Q2 2026 was $128.60M. For the 2026 fiscal year, GB:0K6R's free cash flow was decreased by $-7.80M and operating cash flow was $136.40M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.39 | 3.40 | 2.45 | 2.70 | 3.96 |
| Quick Ratio | 3.30 | 3.28 | 2.40 | 2.64 | 3.83 |
| Cash Ratio | 0.96 | 0.46 | 0.38 | 0.49 | 1.39 |
| Solvency Ratio | 0.37 | 0.33 | 0.27 | 0.26 | 0.14 |
| Operating Cash Flow Ratio | 1.05 | 1.17 | 0.60 | 0.63 | 1.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 2.29 | 2.00 | 0.00 |
| Net Current Asset Value | $ 1.14B | $ 595.70M | $ 587.60M | $ 792.60M | $ 274.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.12 | 0.13 | 0.11 | 0.21 |
| Debt-to-Equity Ratio | 0.13 | 0.18 | 0.19 | 0.15 | 0.32 |
| Debt-to-Capital Ratio | 0.11 | 0.15 | 0.16 | 0.13 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Financial Leverage Ratio | 1.42 | 1.44 | 1.46 | 1.39 | 1.51 |
| Debt Service Coverage Ratio | 0.00 | 3.91 | 1.91 | 1.16 | 4.90 |
| Interest Coverage Ratio | 0.00 | 4.51 | 54.54 | 35.07 | 3.97 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.01 | 0.04 |
| Interest Debt Per Share | 4.17 | 5.79 | 4.43 | 2.82 | 4.93 |
| Net Debt to EBITDA | -0.45 | 0.35 | 0.43 | 0.00 | 0.72 |
| Profitability Margins | |||||
| Gross Profit Margin | 98.18% | 98.56% | 97.90% | 98.44% | 98.74% |
| EBIT Margin | 22.25% | 26.01% | 20.92% | 16.73% | 11.22% |
| EBITDA Margin | 23.30% | 27.16% | 22.05% | 17.77% | 12.18% |
| Operating Profit Margin | 21.64% | 24.22% | 13.30% | 16.73% | 9.04% |
| Pretax Profit Margin | 24.66% | 20.63% | 17.60% | 14.37% | 8.95% |
| Net Profit Margin | 16.73% | 14.49% | 13.23% | 10.38% | 7.90% |
| Continuous Operations Profit Margin | 16.73% | 14.49% | 13.23% | 10.38% | 7.90% |
| Net Income Per EBT | 67.85% | 70.23% | 75.19% | 72.23% | 88.36% |
| EBT Per EBIT | 113.94% | 85.19% | 132.36% | 85.90% | 98.93% |
| Return on Assets (ROA) | 10.33% | 9.18% | 7.68% | 6.52% | 4.32% |
| Return on Equity (ROE) | 14.71% | 13.18% | 11.19% | 9.05% | 6.52% |
| Return on Capital Employed (ROCE) | 15.92% | 17.77% | 9.66% | 13.60% | 5.61% |
| Return on Invested Capital (ROIC) | 10.80% | 12.48% | 6.82% | 8.99% | 4.96% |
| Return on Tangible Assets | 10.33% | 9.28% | 7.76% | 6.63% | 4.32% |
| Earnings Yield | 3.39% | 2.49% | 1.94% | 1.35% | 1.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.16 | 4.92 | 4.30 | 4.25 | 6.11 |
| Payables Turnover | 0.50 | 0.31 | 0.30 | 0.34 | 0.28 |
| Inventory Turnover | 0.76 | 0.59 | 1.04 | 0.66 | 0.47 |
| Fixed Asset Turnover | 5.25 | 3.98 | 5.43 | 10.22 | 7.28 |
| Asset Turnover | 0.62 | 0.63 | 0.58 | 0.63 | 0.55 |
| Working Capital Turnover Ratio | 1.91 | 2.17 | 2.02 | 1.81 | 1.46 |
| Cash Conversion Cycle | -163.87 | -490.43 | -788.46 | -420.78 | -476.28 |
| Days of Sales Outstanding | 87.64 | 74.25 | 84.97 | 85.81 | 59.73 |
| Days of Inventory Outstanding | 483.40 | 616.21 | 352.13 | 552.22 | 778.50 |
| Days of Payables Outstanding | 734.90 | 1180.88 | 1225.55 | 1058.81 | 1314.51 |
| Operating Cycle | 571.03 | 690.45 | 437.10 | 638.03 | 838.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.87 | 5.93 | 3.99 | 3.54 | 2.71 |
| Free Cash Flow Per Share | 7.52 | 5.55 | 3.70 | 3.37 | 2.46 |
| Dividend Paid and CapEx Coverage Ratio | 23.02 | 15.59 | 13.78 | 20.57 | 10.96 |
| Capital Expenditure Coverage Ratio | 23.02 | 15.59 | 13.78 | 20.57 | 10.96 |
| Operating Cash Flow Coverage Ratio | 1.88 | 1.31 | 0.91 | 1.29 | 0.58 |
| Operating Cash Flow to Sales Ratio | 0.27 | 0.25 | 0.21 | 0.23 | 0.23 |
| Free Cash Flow Yield | 5.31% | 4.07% | 2.81% | 2.82% | 2.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 29.49 | 40.15 | 51.55 | 74.06 | 89.92 |
| Price-to-Sales (P/S) Ratio | 4.93 | 5.82 | 6.82 | 7.69 | 7.11 |
| Price-to-Book (P/B) Ratio | 4.34 | 5.29 | 5.77 | 6.70 | 5.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 18.85 | 24.60 | 35.60 | 35.44 | 34.56 |
| Price-to-Operating Cash Flow Ratio | 18.03 | 23.02 | 33.02 | 33.71 | 31.41 |
| Price-to-Earnings Growth (PEG) Ratio | 0.71 | 1.22 | 0.87 | 1.07 | -1.15 |
| Enterprise Value Multiple | 20.72 | 21.77 | 31.36 | 43.24 | 59.06 |
| Enterprise Value | 13.81B | 13.93B | 13.05B | 11.44B | 8.16B |
| EV to EBITDA | 20.72 | 21.77 | 31.36 | 43.24 | 59.06 |
| EV to Sales | 4.83 | 5.91 | 6.92 | 7.69 | 7.20 |
| EV to Free Cash Flow | 18.45 | 24.99 | 36.09 | 35.44 | 34.99 |
| EV to Operating Cash Flow | 17.65 | 23.39 | 33.47 | 33.71 | 31.80 |
| Tangible Book Value Per Share | 32.69 | 25.37 | 22.48 | 17.44 | 14.52 |
| Shareholders’ Equity Per Share | 32.69 | 25.79 | 22.85 | 17.83 | 14.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.32 | 0.30 | 0.25 | 0.28 | 0.12 |
| Revenue Per Share | 28.75 | 23.46 | 19.32 | 15.54 | 11.98 |
| Net Income Per Share | 4.81 | 3.40 | 2.56 | 1.61 | 0.95 |
| Tax Burden | 0.68 | 0.70 | 0.75 | 0.72 | 0.88 |
| Interest Burden | 1.11 | 0.79 | 0.84 | 0.86 | 0.80 |
| Research & Development to Revenue | 0.36 | 0.31 | 0.30 | 0.31 | 0.29 |
| SG&A to Revenue | 0.40 | 0.43 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.08 | 0.08 | 0.10 | 0.12 | 0.12 |
| Income Quality | 1.64 | 1.74 | 1.56 | 2.20 | 2.86 |
Currency in USD
